Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
United Kingdom
/
ETF market
/
CYBO
/
Analysis
VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD
CYBO
London Stock Exchange
CYBO
London Stock Exchange
CYBO
London Stock Exchange
CYBO
London Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
5.09 M
USD
Fund flows (1Y)
−1.03 M
USD
Dividend yield (indicated)
—
Discount/Premium to NAV
0.4%
Shares outstanding
240.00 K
Expense ratio
0.55%
About VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD
Issuer
Van Eck Associates Corp.
Brand
VanEck
Home page
vaneck.com
Inception date
Dec 2, 2022
Structure
Irish VCIC
Index tracked
MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net
Replication method
Physical
Management style
Passive
ISIN
IE0005TF96I9
Functions as an open-end investment fund
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of January 17, 2025
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
99.69%
Health Technology
95.37%
Distribution Services
2.52%
Electronic Technology
1.80%
Bonds, Cash & Other
0.31%
Cash
0.31%
Stock breakdown by region
4%
78%
15%
1%
North America
78.40%
Europe
15.49%
Oceania
4.54%
Asia
1.57%
Latin America
0.00%
Africa
0.00%
Middle East
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows